Ruconest

Medicinal product

(Invented) name

Ruconest

Active substance (s)

Konestatas alfa

Strength

2100 V

Pharmaceutical form

milteliai injekciniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

B06AC04, Conestat alfa

Marketing authorisation holder

Pharming Group N.V., Nyderlandai

Date of authorisation

2010-10-28

Date of renewal

Documents

Ruconest mokomoji medziaga sveikatos prieziuros specialistams.pdf

Ruconest mokomoji medziaga sveikatos prieziuros specialistams imunologiniai verinimai.pdf

Ruconest paciento dienorastis.pdf

Ruconest mokomoji medziaga pacientams.pdf

Ruconest paciento kortele.pdf

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Powder for solution for injection	1 vnt.
Konestatas alfa	2100 V

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
44259	58051	1058051	flakonas	N1		Receptinis	EU/1/10/641/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2010-10-28	Registruotas